{"schema_version":"secwatch.filing_event.v1","accession":"0001801170-26-000214","form_type":"8-K","ticker":"CLOV","cik":"0001801170","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","filed_at":"2026-08-20T20:06:02+00:00","discovered_at":"2026-08-20T20:07:01.389014+00:00","generated_at":"2026-08-20T20:07:12.965485+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Clover Health publishes supplemental Q&A on Q2 2026 results and outlook","bullets":["Clover Health published a supplemental shareholder Q&A on August 20, 2026, addressing Q2 2026 results and 2026 outlook.","The Q&A document, furnished as Exhibit 99.1, includes only an introductory letter from CEO Andrew Toy; no Q&A content is provided in the excerpt.","No specific financial figures, guidance changes, or operational updates are disclosed in the available text."],"urls":{"canonical":"https://secwatch.observer/filing/0001801170-26-000214","json":"https://secwatch.observer/filing/0001801170-26-000214.json","markdown":"https://secwatch.observer/filing/0001801170-26-000214.md","text":"https://secwatch.observer/filing/0001801170-26-000214.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000214/0001801170-26-000214-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000214/clov-20260820.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-20T20:07:12.965485+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}